feed,title,long_url,short_url
Benzinga,Gilead Analysts Downplay Q2 Miss Amid Remdesivir's COVID-19 Opportunity,https://www.benzinga.com/analyst-ratings/analyst-color/20/07/16876975/gilead-analysts-downplay-q2-miss-amid-remdesivirs-covid-19-opportunity,https://j.mp/3fhVNT0
